First human test: can supercharged immune cells stop colon Cancer's return?
NCT ID NCT05394714
Summary
This is an early safety study for a new personalized cell therapy called Magicell-NK. It aims to find a safe dose of these specially grown immune cells for patients with early-stage colon cancer who have already had their tumor surgically removed. Researchers will give the therapy to 18 patients in Taiwan and closely monitor for side effects while also checking if it helps keep the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Linkou
RECRUITINGTaoyuan District, 333, Taiwan
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.